Filing Details
- Accession Number:
- 0001104659-15-086908
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-28 16:30:43
- Reporting Period:
- 2015-12-23
- Filing Date:
- 2015-12-28
- Accepted Time:
- 2015-12-28 16:30:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1157602 | Vitae Pharmaceuticals Inc | VTAE | Pharmaceutical Preparations (2834) | 043567753 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1609879 | S. Jeffrey Hatfield | C/O Vitae Pharmaceuticals, Inc. 502 West Office Center Dr. Fort Washington PA 19034 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-23 | 5,584 | $3.45 | 272,944 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-23 | 16,940 | $3.45 | 289,884 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-23 | 22,524 | $17.00 | 267,360 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-12-28 | 26,537 | $3.45 | 293,897 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-12-23 | 5,584 | $0.00 | 5,584 | $3.45 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-12-23 | 16,940 | $0.00 | 16,940 | $3.45 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2015-12-28 | 26,537 | $0.00 | 26,537 | $3.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-03-28 | No | 4 | M | Direct | |
| 0 | 2016-03-28 | No | 4 | M | Direct | |
| 0 | 2016-03-28 | No | 4 | M | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 25, 2015.
- The option vested in substantially equal installments over 12 months of service following February 15, 2006.
- 8,788 of the option shares vested on March 29, 2007, with the remaining option shares vesting in equal monthly installments over 9 months of service thereafter.
- 2,080 of the option shares vested on March 29, 2007, with the remaining option shares vesting in substantially equal monthly installments over 27 months of service following December 30, 2007.
Billionaire Hedge Funds
